DeepScan Diagnostics is a startup based in France, most recent round Series A, 2 tracked investors.
Based in France, DeepScan Diagnostics is a startup. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
DeepScan Diagnostics develops a comprehensive cancer test capable of detecting the most prevalent cancers in dogs months before clinical signals are shown, improving treatment outcomes. Their tests are sold at veterinary clinics as part of yearly health checks or as standalone tests.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.